Our lab has as a main interest the neurodegenerative process in Parkinson’s disease and other alpha-synucleinopathies. Our main tools of work are animal models of the disease: from neurotoxin based models to transgenic models, both classic transgenic mice lines and adult transgenesis models by means of viral vectors. The team has focused during the last years in those possible events initiated as a consequence of the overexpression and or mishandling of the protein alpha-synuclein that contribute to the disease process. In addition we have an interest on the processes occurring in the immune system during the neurodegenerative event and how both, local and peripheral immune cells, can modify the neuronal survival. Our fundamental goal is to reveal new targets for disease modification that can be ultimately used to develop novel therapies for the patients.

For further information please visit: www.cns.au.dk